Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy.

Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L

Open source

DOI
10.1038/s41571-023-00785-8
Published
2023 Sep
Container
Nature reviews. Clinical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41571-023-00785-8,
  title = {Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy.},
  author = {Thomas AM and Fidelle M and Routy B and Kroemer G and Wargo JA and Segata N and Zitvogel L},
  year = {2023},
  journal = {Nature reviews. Clinical oncology},
  doi = {10.1038/s41571-023-00785-8},
  url = {https://doi.org/10.1038/s41571-023-00785-8}
}

RIS

TY  - JOUR
TI  - Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy.
AU  - Thomas AM
AU  - Fidelle M
AU  - Routy B
AU  - Kroemer G
AU  - Wargo JA
AU  - Segata N
AU  - Zitvogel L
PY  - 2023
JO  - Nature reviews. Clinical oncology
DO  - 10.1038/s41571-023-00785-8
UR  - https://doi.org/10.1038/s41571-023-00785-8
ER  - 

APA

AM, T., M, F., B, R., G, K., JA, W., N, S., & L, Z. (2023). Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy.. Nature reviews. Clinical oncology. https://doi.org/10.1038/s41571-023-00785-8

Source records